Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2010
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science Outlines Objectives For The New Year; Highlights Include Moving Towards Contracts and Licensing Agreements For Research and Development of New Medicines
11-01-11
Cannabis Science President To Appear Today On StockGoodies.com Live Radio Show As Part of National Educational Series On The Ground-Breaking Science of Medical Cannabis At 8:30AM Eastern
13-01-10
Today Cannabis Science Releases Updates To Its Website That Integrates General Public Communications With Recent Developments In Its Analytical, Clinical Research, and Commercial Production Divisions
25-01-10
Cannabis Science Inc. (CBIS) Announces Progress in Bringing the First Cannabis Based Medicine to Market Company Moving Towards Contracts and Licensing Agreements for Research and Development of New Medicines
09-02-10
Cannabis Science Announces Preliminary Results of Its Survey of Cannabis Use By Veterans and Others With Post Traumatic Stress Disorder (PTSD) "Listen to What Our Veterans Are Telling Us"
16-02-10
Cannabis Science Inc. Announces Advances In Its Analytical Lab Logistics
22-02-10
Cannabis Science Moves Its FDA Clinical Trial Process Forward
25-02-10
Cannabis Science Officially Begins Its First Pre-IND FDA Application Process For Post Traumatic Stress Disorder (PTSD)
01-03-10
Cannabis Science Sets Second FDA Drug Target on $20 Billion "Chronic Pain" Market Targeting the Huge Need for Safe Non-Addictive Non-Lethal Cannabis Based Medications
04-03-10
Highly Specialized International FDA Regulatory Compliance Firm Signs With Cannabis Science to Prepare for Company's First Pre-Investigative New Drug (IND) Submission Package for Veterans PTSD Project
08-03-10
Start
Prev
1
2
3
4
5
Next
End